Latest Insider Transactions at Co Diagnostics, Inc. (CODX)
This section provides a real-time view of insider transactions for Co Diagnostics, Inc. (CODX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Co-Diagnostics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Co-Diagnostics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 23
2022
|
Brian Lee Brown Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,666
+35.06%
|
-
|
|
Jan 08
2022
|
Eugene Durenard |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
Jan 08
2022
|
Ted Murphy |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+33.33%
|
-
|
|
Jan 08
2022
|
James B Nelson |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
Jan 08
2022
|
Richard S Serbin |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+45.45%
|
-
|
|
Nov 23
2021
|
Brian Lee Brown Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,684
-26.58%
|
$53,472
$8.44 P/Share
|
|
Nov 23
2021
|
Brian Lee Brown Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,667
+46.29%
|
-
|
|
Nov 23
2021
|
Dwight H Egan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,544
-38.66%
|
$124,352
$8.44 P/Share
|
|
Nov 23
2021
|
Dwight H Egan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
33,333
+45.33%
|
-
|
|
Sep 08
2021
|
Eugene Durenard |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$20,000
$10.46 P/Share
|
|
May 24
2021
|
Reed L Benson General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,414
-30.85%
|
$9,898
$7.9 P/Share
|
|
May 24
2021
|
Reed L Benson General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
4,584
+50.0%
|
-
|
|
May 24
2021
|
Dwight H Egan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,628
-45.02%
|
$39,396
$7.9 P/Share
|
|
May 24
2021
|
Dwight H Egan Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
|
May 24
2021
|
Brian Lee Brown Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,524
-30.48%
|
$10,668
$7.9 P/Share
|
|
May 24
2021
|
Brian Lee Brown Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+50.0%
|
-
|
|
May 19
2021
|
Reed L Benson General Counsel |
SELL
Open market or private sale
|
Direct |
108,334
-70.03%
|
$866,672
$8.53 P/Share
|
|
May 19
2021
|
Reed L Benson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
108,334
+49.11%
|
$216,668
$2.12 P/Share
|
|
Jan 15
2021
|
Dwight H Egan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
38,046
-100.0%
|
$418,506
$11.0 P/Share
|
|
Jan 15
2021
|
Dwight H Egan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,954
-23.91%
|
$23,908
$2.63 P/Share
|
|
Jan 15
2021
|
Dwight H Egan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$100,000
$2.63 P/Share
|
|
Jan 14
2021
|
Richard S Serbin |
SELL
Open market or private sale
|
Direct |
10,000
-80.0%
|
$100,000
$10.29 P/Share
|
|
Jan 13
2021
|
James B Nelson |
SELL
Open market or private sale
|
Direct |
12,500
-97.6%
|
$125,000
$10.14 P/Share
|
|
Jan 13
2021
|
Eugene Durenard |
SELL
Open market or private sale
|
Direct |
10,500
-84.0%
|
$105,000
$10.09 P/Share
|
|
Dec 14
2020
|
Richard S Serbin |
SELL
Open market or private sale
|
Direct |
17,000
-100.0%
|
$170,000
$10.1 P/Share
|
|
Dec 10
2020
|
Eugene Durenard |
SELL
Open market or private sale
|
Direct |
10,000
-100.0%
|
$100,000
$10.15 P/Share
|
|
Nov 25
2020
|
Reed L Benson General Counsel |
SELL
Open market or private sale
|
Direct |
89,524
-100.0%
|
$895,240
$10.5 P/Share
|
|
Nov 25
2020
|
Reed L Benson General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
10,476
-10.48%
|
$10,476
$1.1 P/Share
|
|
Nov 25
2020
|
Reed L Benson General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
100,000
+50.0%
|
$100,000
$1.1 P/Share
|
|
Nov 24
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
44,764
-100.0%
|
$447,640
$10.51 P/Share
|
|
Nov 24
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,236
-10.47%
|
$5,236
$1.1 P/Share
|
|
Nov 24
2020
|
Dwight H Egan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+50.0%
|
$50,000
$1.1 P/Share
|
|
Nov 23
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
71,569
-100.0%
|
$715,690
$10.44 P/Share
|
|
Nov 23
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,431
-10.54%
|
$8,431
$1.1 P/Share
|
|
Nov 23
2020
|
Dwight H Egan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
80,000
+50.0%
|
$80,000
$1.1 P/Share
|
|
Nov 23
2020
|
Richard S Serbin |
BUY
Exercise of conversion of derivative security
|
Direct |
17,000
+50.0%
|
-
|
|
Nov 23
2020
|
Eugene Durenard |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
|
Nov 20
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,017
-100.0%
|
$198,187
$11.09 P/Share
|
|
Nov 20
2020
|
Dwight H Egan Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,983
-9.92%
|
$1,983
$1.1 P/Share
|
|
Nov 20
2020
|
Dwight H Egan Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$20,000
$1.1 P/Share
|
|
Apr 01
2020
|
Reagents, LLC |
SELL
Other acquisition or disposition
|
Direct |
25,000
-1.41%
|
$4,812,625,000
$192505.0 P/Share
|
|
Sep 19
2017
|
Reagents, LLC |
SELL
Other acquisition or disposition
|
Direct |
181,817
-9.31%
|
-
|